| GOLDMAN SACHS EMERGING MARKETS CORE EQUITY PORTFOLIO P (CLOSE) USD CAP | RVI EMERGENTES | 29,35% | 73,22% | 52,66% | 134,15% |
| JPM THEMATICS-GENETIC THERAPIES C (DIST) USD | RVI BIOTECNOLOGÍA | 29,35% | 36,24% | -14,79% | · |
| NOMURA FUNDS IRELAND - ASIA EX JAPAN HIGH CONVICTION FUND I EUR | RVI ASIA EX-JAPÓN | 29,35% | 67,47% | 32,73% | · |
| JANUS HENDERSON GLOBAL TECHNOLOGY AND INNOVATION B2 USD | RVI TECNOLOGÍA | 29,34% | 105,63% | 83,77% | 463,45% |
| LO FUNDS - TARGETNETZERO EMERGING MARKETS EQUITY SEED (EUR) N CAP | RVI EMERGENTES | 29,34% | 77,50% | 11,18% | 9,47% |
| T.ROWE GLOBAL VALUE EQUITY FUND EDS (EUR) | RVI GLOBAL VALOR | 29,33% | 73,56% | · | · |
| XTRACKERS BLOOMBERG COMMODITY EX-AGRICULTURE & LIVESTOCK SWAP UCITS ETF 1C EUR HEDGED | RVI MATERIAS PRIMAS | 29,33% | 49,93% | 51,75% | 102,85% |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) GBP (HEDGED) | RVI BIOTECNOLOGÍA | 29,32% | 47,91% | -16,78% | · |
| T.ROWE EMERGING MARKETS DISCOVERY EQUITY FUND I9 | RVI EMERGENTES | 29,31% | 75,54% | 63,83% | · |
| T.ROWE GLOBAL VALUE EQUITY FUND EDS (GBP) | RVI GLOBAL VALOR | 29,31% | 73,60% | · | · |
